2005 - Editors Choice

Citations 1-10 of 10 total displayed.

Most recent content (1 Oct 2005):

Epidemiology
Lung cancer mortality in European women: recent trends and perspectives

C. Bosetti, F. Levi, F. Lucchini, E. Negri, and C. La Vecchia
Ann. Onc. 2005; 16: 1597-1604. [Abstract] [Full text] [PDF]  

Past content (since Jan 2005):

Editorials
ESMO at 30: Mission ongoing

P. A. Kosmidis, H. Ludwig, and H. Mellstedt
Ann. Onc. 2005; 16: 1411-1412. [Extract] [Full text] [PDF]  

Breast Cancer
A comparative analysis of radiotherapy use and patient outcome in males and females with breast cancer

G. Macdonald, C. Paltiel, I. A. Olivotto, and S. Tyldesley
Ann. Onc. 2005; 16: 1442-1448. [Abstract] [Full text] [PDF]  

Breast cancer
Cyclophosphamide-methotrexate ‘metronomic’ chemotherapy for the palliative treatment of metastatic breast cancer. A comparative pharmacoeconomic evaluation

G. Bocci, M. Tuccori, U. Emmenegger, V. Liguori, A. Falcone, R. S. Kerbel, and M. Del Tacca
Ann. Onc. 2005; 16: 1243-1252. [Abstract] [Full text] [PDF] [ Supplementary Data ]  

Breast cancer
The influence of letrozole on serum lipid concentrations in postmenopausal women with primary breast cancer who have completed 5 years of adjuvant tamoxifen (NCIC CTG MA.17L)

K. M. Wasan, P. E. Goss, P. H. Pritchard, L. Shepherd, M. J. Palmer, S. Liu, D. Tu, J. N. Ingle, M. Heath, D. DeAngelis, and E. A. Perez
Ann. Onc. 2005; 16: 707-715. [Abstract] [Full text] [PDF]  

Oncology practice
Use of complementary and alternative medicine in cancer patients: a European survey

A. Molassiotis, P. Fernadez-Ortega, D. Pud, G. Ozden, J. A. Scott, V. Panteli, A. Margulies, M. Browall, M. Magri, S. Selvekerova, E. Madsen, L. Milovics, I. Bruyns, G. Gudmundsdottir, S. Hummerston, A. M.-A. Ahmad, N. Platin, N. Kearney, and E. Patiraki
Ann. Onc. 2005; 16: 655-663. [Abstract] [Full text] [PDF]  

Breast Cancer
Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin^TM) in breast cancer cells with Her-2/neu oncogene amplification

J. A. Menendez, L. Vellon, R. Colomer, and R. Lupu
Ann. Onc. 2005; 16: 359-371. [Abstract] [Full text] [PDF]  

Epidemiology
Cancer incidence and mortality in Europe, 2004

P. Boyle and J. Ferlay
Ann. Onc. 2005; 16: 481-488. [Abstract] [Full text] [PDF]  

Hematologic malignancies
Home care versus hospital care of patients with hematological malignancies and chemotherapy-induced cytopenia

F. H. van Tiel, M. M. Harbers, A. G. Kessels, and H. C. Schouten
Ann. Onc. 2005; 16: 195-205. [Abstract] [Full text] [PDF]  

Gynecologic tumors
Does the nadir CA125 concentration predict a long-term outcome after chemotherapy for carcinoma of the ovary?

S. M. Crawford and J. Peace
Ann. Onc. 2005; 16: 47-50. [Abstract] [Full text] [PDF]